Article Information
History
- September 27, 2023.
Article Versions
- Version 1 (July 25, 2020 - 00:57).
- Version 2 (September 2, 2020 - 15:42).
- Version 3 (September 24, 2020 - 15:54).
- Version 4 (October 6, 2020 - 11:18).
- Version 5 (November 23, 2020 - 11:09).
- Version 6 (February 11, 2021 - 14:42).
- Version 7 (April 9, 2021 - 09:07).
- Version 8 (April 11, 2021 - 09:43).
- Version 9 (April 16, 2021 - 08:26).
- Version 10 (July 14, 2021 - 14:26).
- Version 11 (July 28, 2021 - 13:55).
- Version 12 (August 26, 2021 - 11:41).
- Version 13 (September 10, 2021 - 11:03).
- Version 14 (January 5, 2022 - 11:07).
- Version 15 (April 13, 2022 - 08:50).
- Version 16 (September 1, 2023 - 11:21).
- You are viewing Version 17, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- ISARIC Clinical Characterisation Group*,
- J. Kenneth Baillie1,
- Joaquin Baruch2,
- Abigail Beane3,
- Lucille Blumberg4,
- Fernando Augusto Bozza5,
- Tessa Broadley6,
- Aidan Burrell6,
- Gail Carson2,
- Barbara Wanjiru Citarella2,
- Jake Dunning2,
- Loubna Elotmani7,
- Noelia Garcia Barrio8,
- Jean-Christophe Goffard9,
- Matthew Hall2,
- Madiha Hashmi11,
- Peter Horby2,
- Waasila Jassat4,
- Christiana Kartsonaki2,
- Bharath Kumar Tirupakuzhi Vijayaraghavan12,
- Pavan Kumar Vecham13,
- Cedric Laouenan14,
- Samantha Lissauer15,
- Ignacio Martin-Loeches16,
- France Mentre14,
- Ben Morton17,
- Daniel Munblit18,
- Nikita A. Nekliudov18,
- Alistair Nichol19,
- David S.Y. Ong20,
- Prasan Kumar Panda21,
- Miguel Pedrera Jimenez8,
- Michelle Petrovic22,
- Nagarajan Ramakrishnan13,
- Grazielle Viana Ramos5,
- Claire Roger7,
- Amanda Rojek2,
- Oana Sandulescu23,
- Malcolm G. Semple24,
- Pratima Sharma25,
- Sally Shrapnel26,
- Louise Sigfrid2,
- Benedict Sim Lim Heng27,
- Budha Charan Singh21,
- Emily Somers28,
- Anca Streinu-Cercel23,
- Fabio S. Taccone29,
- Jia Wei2,
- Evert-Jan Wils20,
- Xin Ci Wong27,
- Kyle Young26,
- Piero L. Olliaro2 and
- Laura Merson2,^
- 1ISARIC 4C and Roslin Institute, University of Edinburgh, UK
- 2International Severe Acute Respiratory and emerging Infections Consortium (ISARIC), University of Oxford, UK
- 3Critical Care Asia, Thailand
- 4National Institute for Communicable Diseases, South Africa
- 5National Institute of Infectious Disease Evandro Chagas, Oswaldo Cruz Foundation (INI-FIOCRUZ), Ministry of Health, and D? Or Institute of Research and Education (IDOR), Brazil
- 6Monash University, Australia
- 7CHU Caremeau, France
- 8Hospital 12 de Octubre, Spain
- 9CUB-Hopital Erasme, Belgium
- 10University of Oxford, UK
- 11Critical Care Asia and Ziauddin University, Pakistan
- 12Critical Care Asia Network, India
- 13Apollo Hospitals Chennai, India
- 14INSERM, France
- 15Malawi-Liverpool Wellcome Trust, Malawi
- 16St James’s Hospital, Ireland
- 17Liverpool School of Tropical Medicine, UK and Malawi-Liverpool Wellcome Trust, Malawi
- 18Sechenov University, Russia
- 19Irish Critical Care Critical Clinical Trials Network, Ireland
- 20Franciscus Gasthuis & Vlietland, The Netherlands
- 21All India Institute of Medical Sciences, India
- 22Humber River Hospital, Canada
- 23National Institute for Infectious Diseases Matei Bals, Romania
- 24ISARIC 4C and University of Liverpool, UK
- 25University of Michigan Schools of Medicine & Public Health, USA
- 26University of Queensland - Saint Lucia Campus: The University of Queensland
- 27National Institutes of Health (NIH), Ministry of Health Malaysia
- 28University of Michigan, USA
- 29CUB-Hopital Erasme, France
- ↵^Correspondence to: Laura.Merson{at}ndm.ox.ac.uk, ISARIC, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK